The Effect of Needle Placement on Muscle Stiffness, Gait, Balance, Pain and Functional Outcomes in Individuals With Injury to the Ankle and/or Hindfoot
- Conditions
- Ankle and or Hindfoot Injury
- Interventions
- Other: Dry Needling
- Registration Number
- NCT04487327
- Lead Sponsor
- Regis University
- Brief Summary
The purpose of this randomized controlled trial is to assess the effect of DN at either the site of the identified myofascial trigger point/s (MTrP) of in the same muscle, but away from the MTrP site/s in individuals with ankle and/or hindfoot injury. Assessments will be of self-reported outcomes, self-reported pain, gait, balance, muscle stiffness, and pain pressure threshold. The secondary purpose of this study is to determine the validity of dry needling specific muscles of the lower extremity based upon needle placement, location relative to anatomical structures and accuracy of needle placement in muscle using ultrasound imaging.
- Detailed Description
Few studies have assessed the validity of needling muscles of the lower extremity. For muscles such as the tibialis posterior that are not easily accessible or directly palpable secondary to the deep anatomical position and due to the proximity of the tibial nerve and the posterior tibial artery within the deep compartment, examining accurate needle placement is clinically relevant. In addition, DN has been shown to be a beneficial management strategy for individuals with lower extremity condition; however, the investigators may be able to optimize these beneficial effects by performing DN on the MTrP versus other sites within the same muscle.
If needling directly into the MTrP is more effective than needling away from the MTrP but into the same muscle, it is possible that the improved efficiency could help to optimize management of patients with injury to the ankle/hindfoot with less visits and potentially decreasing health care costs.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 75
- Participants with a previous lower extremity injury occurring to the ankle and/or hindfoot within the previous 12 months AND
- pain greater than 3 out of 10 on the numeric pain rating scale (NPRS) OR
- limited weightbearing dorsiflexion range of motion of greater than 2.0 cm side-to-side difference as measured by the ankle lunge test (ALT) OR
- greater than 3.5% side-to-side difference as assessed by the Y-balance test.
- Operative fixation within the past 3 months to the lower extremity
- Have received DN of the lower extremity within the past 30 days
- Current pregnancy
- Have a history of systemic disorders in which DN would be contraindicated (bleeding disorders or current anticoagulant medication use)
- Immunocompromised
- Decline participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Dry Needling within the Myofascial Trigger Point Dry Needling Randomized to receive DN at the site of the MTrP Dry Needling away from Myofascial Trigger Point Site Dry Needling Randomized to receive DN 2 cm away from the site of the MTrP but within the same muscle
- Primary Outcome Measures
Name Time Method DN location effect on self-reported and clinical outcomes 2 year Foot and Ankle Ability Measure (FAAM)
DN location effect on clinical outcomes - Muscle Stiffness 2 year Muscle Stiffness Measured with the MyotonPro
DN location effect on clinical outcomes - Gait 2 year Plantar pressure during gait measured by the EMED system and GAITRite
DN location effect on clinical outcomes - Dynamic Balance 2 year Balance measured by the Y-balance test
DN location effect on clinical outcomes - PPT 2 year Pain pressure threshold measured by an algometer
- Secondary Outcome Measures
Name Time Method Validation of needle placement in lower extremity muscles 6 month Individuals will receive dry needling with the aseptic technique previously described. With the needle in place, diagnostic ultrasound will be performed. The accuracy of the needle placement will be assessed and the distance from the needle to major arteries, nerve, and veins will be measured in millimeters and documented. Only one visit lasting approximately 30 minutes will be required for this portion of the study.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Regis University
🇺🇸Denver, Colorado, United States